^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Undisclosed EGFR/B7H3 CAR-T

    i
    Other names: Undisclosed EGFR/B7H3 CAR-T
    Associations

    News

    Trials
    Company:
    Guangzhou Medical University, Hedy Group
    Drug class:
    B7-H3-targeted CAR-T immunotherapy, EGFR-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    2years
    EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer (clinicaltrials.gov)
    P1, N=30, Recruiting, Second Affiliated Hospital of Guangzhou Medical University
    New P1 trial
    |
    EGFR (Epidermal growth factor receptor) • CD276 (CD276 Molecule)
    |
    EGFR expression • CD276 expression
    |
    Undisclosed EGFR/B7H3 CAR-T